Login / Signup

Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.

Phoebe FriesenArthur L CaplanJennifer E Miller
Published in: Journal of clinical pharmacy and therapeutics (2019)
Multicentre formulary development, where resources are pooled across institutions, may lead to a reduction in the influence of conflicts of interest in pharmacy and therapeutics committee processes in the United States, increasing the chances of including the most safe, efficacious and cost-effective drugs on formularies.
Keyphrases
  • clinical trial
  • small molecule
  • study protocol
  • double blind